Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
Baycol is a prescription drug manufactured by Bayer Pharmaceuticals. Baycol, which was initially approved by the FDA, belongs to a statin group of drugs that lowers cholesterol by blocking enzymes that are essential in the synthesis of cholesterol in the body. ....Bayer Pharmaceuticals has voluntarily recalled its cholesterol drug Baycol( cerivastatin ) because // it has been linked to approximat...Bayer Wins Positive Response For Marketing Its Cancer Drug
European officials have given the green signal for Bayer AG and its partner Onyx Pharmaceuticals Inc., for marketing their new drug to treat kidney cancer//. ....The opinion of the European Committee for Medicinal Products for Human Use (CHMP) of the drug Nexavar would now be passed onto the European Commission. ....A positive ruling by the commission could pave the way for a marketing authorisa...Genomatix Licensed By Bayer Healthcare
Genomatix is a microarray platform which is now licensed by Bayer HealthCare. It enables biologists and bio-informaticians to analyze chip raw data//. ..It employs the latest genomic annotation. ..It combines both literature and pathway mining in a single coherent system. ‘After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector. ..We expect...Bayer to Market Biocon Insulin in China
Indian biotech major Biocon Ltd has roped in Bayer HealthCare to market its recombinant human insulin Insugen in the Chinese market, the company //said in a statement Wednesday. ....The Bangalore-based biotech firm plans to launch Insugen in China by 2007-08 after completing the registration trials and seeking the regulatory approvals. ...."The marketing tie-up with Bayer will be extended to ot...Test for Esophageal Reflux Licensed to Bayer by University
A new test for esophageal reflux disease developed by a Wake Forest University Health Sciences (WFUHS) otolaryngologist has been licensed to Bayer HealthCare’s Diagnostics Division by WFUHS.// ..The test, which detects the presence of human pepsin 3b in a patient’s saliva, was developed by Jamie Koufman, M.D., then professor of otolaryngology at Wake Forest University School of Medicine and direc...Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
Bayer HealthCare Pharmaceuticals Inc. (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a Supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. ...Nexavar is currently approve...The Dow Chemical Company and the Bayer Group today announced the closing of Dow's acquisition of Wolff Walsrode. The purchase price of EUR 540 million (approximately USD 725 million) includes a cash component and the assumption of financial debt and pension commitments. Following regulatory clearance from various authorities around the world, payment and share transfers have occurred, and Dow ha...